Showing results (411-420 of 485) with videos related to

Sort By:
Pageof 49
Obesity (Silver Spring, Md.)|June 16, 2026
Dietary Protein Reduction During Isocaloric Conditions Reduces Body Weight in Men With Overweight or ObesityAslak E Lyster, Amalie S Frederiksen, Jacob K Jensen, et al.
British Journal of Haematology|August 24, 2006
Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in childrenWolfgang Schwinger, Daniela Weber-Mzell, Birgit Zois, et al.
Geroscience|April 19, 2021
Ageing affects subtelomeric DNA methylation in blood cells from a large European population enrolled in the MARK-AGE studyMaria Giulia Bacalini, Anna Reale, Marco Malavolta, et al.
European Journal of Preventive Cardiology|October 1, 2024
Exposure to aircraft noise exacerbates cardiovascular and oxidative damage in three mouse models of diabetesDominika Mihalikova, Paul Stamm, Miroslava Kvandova, et al.
Journal of Neurosurgery. Pediatrics|August 3, 2010
Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT databaseMartin Benesch, Daniela Weber-Mzell, Nicolas U Gerber, et al.
Plos One|September 22, 2017
The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantationDaniela Weber, Katrin Frauenschläger, Sakhila Ghimire, et al.
Aging Cell|March 13, 2026
Biologically Younger Individuals, as Identified by MARK-AGE Biological Age Scores, Display a Distinct Favourable Blood Chemistry Profile Regardless of AgeMaría Moreno-Villanueva, Michael Junk, Grażyna Mosieniak, et al.
Cardiovascular Research|May 7, 2020
Quantifying technical confounders in microbiome studiesTheda U P Bartolomaeus, Till Birkner, Hendrik Bartolomaeus, et al.
Frontiers in Immunology|January 11, 2021
Potential Novel Biomarkers in Chronic Graft-Versus-Host DiseaseRachel E Crossland, Francesca Perutelli, Katarzyna Bogunia-Kubik, et al.
British Journal of Haematology|March 31, 2015
A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutationsWalter Fiedler, Sabine Kayser, Maxim Kebenko, et al.
Pageof 49